T Cell Specific Surface Glycoprotein CD28 Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

T Cell Specific Surface Glycoprotein CD28 Market Report 2026

Name: T Cell Specific Surface Glycoprotein CD28 Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (FPT 155, FR 104, Lulizumab Pegol, Other Types), By Technology (Flow Cytometry, EnzymeLinked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Weste Blotting, Immunohistochemistry), By Distribution Channel (Direct Sales, Distributors, Ecommerce, Retail Pharmacies, Wholesalers), By Application (Immunology Research, Cancer Research, Autoimmune Diseases, Infectious Diseases, Stem Cell Research), By End-User (Hospitals, Research Laboratories, Academic Institutions, Pharmaceutical Companies, Diagnostic Laboratories) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

T Cell Specific Surface Glycoprotein CD28 Market Overview

• T Cell Specific Surface Glycoprotein CD28 market size has reached to $1.62 billion in 2025

• Expected to grow to $2.58 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%

• Growth Driver: Growing Emphasis On Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Technologies

• Market Trend: Breakthrough CD28 Approach Aims To Minimize Off-Target Toxicity In Cancer Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under T Cell Specific Surface Glycoprotein CD28 Market?

T cell-specific surface glycoprotein CD28 is a co-stimulatory receptor expressed on the surface of most T cells. It binds to B7 molecules (CD80/CD86) on antigen-presenting cells, delivering essential secondary signals for T cell activation, proliferation, and survival. Its primary purpose is to enhance immune responses by promoting cytokine production and preventing T cell anergy.

The main types of T cell specific surface glycoprotein CD28 include FPT155, FR104, Lulizumab Pegol, and others. FPT155 is an investigational therapeutic protein that functions as an immune co-stimulatory fusion protein, targeting CD80 to activate T cells and enhance anti-tumor immune responses. These products utilize various technologies such as flow cytometry, enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), western blotting, and immunohistochemistry, and are distributed through various channels including direct sales, distributors, e-commerce, retail pharmacies, and wholesalers. They are used in diverse applications such as immunology research, cancer research, autoimmune diseases, infectious diseases, and stem cell research, with key end users including hospitals, research laboratories, academic institutions, pharmaceutical companies, and diagnostic laboratories.

T Cell Specific Surface Glycoprotein CD28 Market Global Report 2026 Market Report bar graph

What Is The T Cell Specific Surface Glycoprotein CD28 Market Size and Share 2026?

The t cell specific surface glycoprotein cd28 market size has grown strongly in recent years. It will grow from $1.62 billion in 2025 to $1.78 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to early identification of cd28 as a t-cell co-stimulatory receptor, growing immunology research, increasing prevalence of autoimmune diseases, rising cancer research initiatives, limited availability of monoclonal antibody therapies.

What Is The T Cell Specific Surface Glycoprotein CD28 Market Growth Forecast?

The t cell specific surface glycoprotein cd28 market size is expected to see strong growth in the next few years. It will grow to $2.58 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to development of lulizumab pegol and novel cd28 inhibitors, expansion of preclinical and clinical trials, integration of cd28-targeted therapies in autoimmune and cancer treatments, rising investment in biopharmaceutical research, advancement in immunomodulation and monoclonal antibody engineering. Major trends in the forecast period include increasing adoption of flow cytometry and elisa technologies, growth in immunology and cancer research applications, rising development of novel cd28 inhibitors and biobetters, expansion of stem cell and autoimmune disease research, integration of lulizumab pegol in preclinical and clinical studies.

Book your 30 minutes free consultation with our research experts

Global T Cell Specific Surface Glycoprotein CD28 Market Segmentation

1) By Type: FPT 155, FR 104, Lulizumab Pegol, Other Types

2) By Technology: Flow Cytometry, EnzymeLinked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Weste Blotting, Immunohistochemistry

3) By Distribution Channel: Direct Sales, Distributors, Ecommerce, Retail Pharmacies, Wholesalers

4) By Application: Immunology Research, Cancer Research, Autoimmune Diseases, Infectious Diseases, Stem Cell Research

5) By End-User: Hospitals, Research Laboratories, Academic Institutions, Pharmaceutical Companies, Diagnostic Laboratories

Subsegments:

1) By FPT 155: Preclinical Studies, Clinical Trials, Oncology Applications, Licensing And Partnerships

2) By FR 104: Autoimmune Disease Applications, Rheumatoid Arthritis Trials, Transplant Rejection Studies, Research Collaborations

3) By Lulizumab Pegol: Systemic Lupus Erythematosus (SLE) Studies, Immunomodulation Research, Biopharmaceutical Development, Monoclonal Antibody Engineering

4) By Other Types: Novel CD28 Inhibitors, Combination Therapies, Biosimilars And Biobetters, Emerging Research Compounds

What Is The Driver Of The T Cell Specific Surface Glycoprotein CD28 Market?

The growing emphasis on personalized medicine is expected to propel the growth of the T cell-specific surface glycoprotein CD28 market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable precise identification of genetic variations and tailored treatments for individuals. T cell-specific surface glycoprotein CD28 supports personalized medicine by enabling targeted immune modulation, making therapies more precise and effective. It enhances treatment outcomes by promoting optimal T cell activation, improving patient-specific immune responses. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, an increase from 12 approved in 2022. Therefore, the growing emphasis on personalized medicine is driving the growth of the T cell-specific surface glycoprotein CD28 market.

Key Players In The Global T Cell Specific Surface Glycoprotein CD28 Market

Major companies operating in the t cell specific surface glycoprotein cd28 market are Gilead Sciences Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Becton Dickinson and Company, Regeneron Pharmaceuticals Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Sino Biological Inc., Xencor Inc., ACROBiosystems Co. Ltd., Fate Therapeutics Inc., Medigene AG, Alpine Immune Sciences Inc., Adaptimmune Therapeutics plc, OSE Immunotherapeutics SA, Creative Biolabs Inc., Rondo Therapeutics Inc.

Global T Cell Specific Surface Glycoprotein CD28 Market Trends and Insights

Major companies operating in the T cell-specific surface glycoprotein CD28 market are focusing on developing innovative products, such as the combination immunotherapies, to enhance T cell activation, anti-tumor efficacy, and patient treatment outcomes. Combination immunotherapies are treatments that combine multiple immune-based approaches to boost the body’s ability to fight disease. For instance, in February 2025, Rondo Therapeutics Inc., a US-based biopharmaceutical company, revealed preclinical data on RNDO 564, a novel CD28 Nectin 4 costimulatory bispecific antibody for advanced bladder cancer. It is engineered to selectively activate CD28 on T cells upon binding to Nectin-4-expressing tumor cells, enhancing T-cell-mediated tumor killing while minimizing off-target toxicity. The data demonstrated potent anti-tumor activity in preclinical models, supporting further development as a potential therapy for patients with metastatic urothelial carcinoma.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The T Cell Specific Surface Glycoprotein CD28 Market?

In December 2024, Rondo Therapeutics Inc., a US-based biopharmaceutical company, partnered with Eli Lilly and Company to develop new CD28 bispecific antibodies for solid tumors. This partnership aims to enhance T cell co-stimulation and improve anti-tumor immune responses while minimizing immune-related toxicity, thereby advancing next-generation immuno-oncology therapies. Eli Lilly and Company is a US-based biopharmaceutical company developing CD28-targeted immuno-oncology therapies.

Regional Insights

North America was the largest region in the T cell-specific surface glycoprotein CD28 market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the T Cell Specific Surface Glycoprotein CD28 Market?

The T cell-specific surface glycoprotein CD28 market consists of revenues earned by entities by providing services such as drug discovery, antibody development, cell signaling assays, immuno-oncology research, diagnostic testing, and clinical trial support targeting CD28 pathways. The market value includes the value of related goods sold by the service provider or included within the service offering. The T cell-specific surface glycoprotein CD28 market also includes sales of CD28 fusion proteins, CD28 ligands, flow cytometry reagents, and diagnostic assays and kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the T Cell Specific Surface Glycoprotein CD28 Market Report 2026?

The t cell specific surface glycoprotein cd28 market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the t cell specific surface glycoprotein cd28 industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

T Cell Specific Surface Glycoprotein CD28 Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.78 billion
Revenue Forecast In 2035	$2.58 billion
Growth Rate	CAGR of 10.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Technology, Distribution Channel, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Gilead Sciences Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Becton Dickinson and Company, Regeneron Pharmaceuticals Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. T Cell Specific Surface Glycoprotein CD28 Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global T Cell Specific Surface Glycoprotein CD28 Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. T Cell Specific Surface Glycoprotein CD28 Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global T Cell Specific Surface Glycoprotein CD28 Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Flow Cytometry And ELISA Technologies

4.2.2 Growth In Immunology And Cancer Research Applications

4.2.3 Rising Development Of Novel CD28 Inhibitors And Biobetters

4.2.4 Expansion Of Stem Cell And Autoimmune Disease Research

4.2.5 Integration Of Lulizumab Pegol In Preclinical And Clinical Studies

5. T Cell Specific Surface Glycoprotein CD28 Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Research Laboratories

5.3 Academic Institutions

5.4 Pharmaceutical Companies

5.5 Diagnostic Laboratories

6. T Cell Specific Surface Glycoprotein CD28 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global T Cell Specific Surface Glycoprotein CD28 Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global T Cell Specific Surface Glycoprotein CD28 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global T Cell Specific Surface Glycoprotein CD28 Market Size, Comparisons And Growth Rate Analysis

7.3. Global T Cell Specific Surface Glycoprotein CD28 Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global T Cell Specific Surface Glycoprotein CD28 Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global T Cell Specific Surface Glycoprotein CD28 Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. T Cell Specific Surface Glycoprotein CD28 Market Segmentation

9.1. Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

FPT 155, FR 104, Lulizumab Pegol, Other Types

9.2. Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Flow Cytometry, EnzymeLinked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Weste Blotting, Immunohistochemistry

9.3. Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Distributors, Ecommerce, Retail Pharmacies, Wholesalers

9.4. Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunology Research, Cancer Research, Autoimmune Diseases, Infectious Diseases, Stem Cell Research

9.5. Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Research Laboratories, Academic Institutions, Pharmaceutical Companies, Diagnostic Laboratories

9.6. Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of FPT 155, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preclinical Studies, Clinical Trials, Oncology Applications, Licensing And Partnerships

9.7. Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of FR 104, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autoimmune Disease Applications, Rheumatoid Arthritis Trials, Transplant Rejection Studies, Research Collaborations

9.8. Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of Lulizumab Pegol, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Systemic Lupus Erythematosus (SLE) Studies, Immunomodulation Research, Biopharmaceutical Development, Monoclonal Antibody Engineering

9.9. Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Novel CD28 Inhibitors, Combination Therapies, Biosimilars And Biobetters, Emerging Research Compounds

10. T Cell Specific Surface Glycoprotein CD28 Market Regional And Country Analysis

10.1. Global T Cell Specific Surface Glycoprotein CD28 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global T Cell Specific Surface Glycoprotein CD28 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market

11.1. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China T Cell Specific Surface Glycoprotein CD28 Market

12.1. China T Cell Specific Surface Glycoprotein CD28 Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India T Cell Specific Surface Glycoprotein CD28 Market

13.1. India T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan T Cell Specific Surface Glycoprotein CD28 Market

14.1. Japan T Cell Specific Surface Glycoprotein CD28 Market Overview

14.2. Japan T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia T Cell Specific Surface Glycoprotein CD28 Market

15.1. Australia T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia T Cell Specific Surface Glycoprotein CD28 Market

16.1. Indonesia T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea T Cell Specific Surface Glycoprotein CD28 Market

17.1. South Korea T Cell Specific Surface Glycoprotein CD28 Market Overview

17.2. South Korea T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan T Cell Specific Surface Glycoprotein CD28 Market

18.1. Taiwan T Cell Specific Surface Glycoprotein CD28 Market Overview

18.2. Taiwan T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia T Cell Specific Surface Glycoprotein CD28 Market

19.1. South East Asia T Cell Specific Surface Glycoprotein CD28 Market Overview

19.2. South East Asia T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe T Cell Specific Surface Glycoprotein CD28 Market

20.1. Western Europe T Cell Specific Surface Glycoprotein CD28 Market Overview

20.2. Western Europe T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK T Cell Specific Surface Glycoprotein CD28 Market

21.1. UK T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany T Cell Specific Surface Glycoprotein CD28 Market

22.1. Germany T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France T Cell Specific Surface Glycoprotein CD28 Market

23.1. France T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy T Cell Specific Surface Glycoprotein CD28 Market

24.1. Italy T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain T Cell Specific Surface Glycoprotein CD28 Market

25.1. Spain T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe T Cell Specific Surface Glycoprotein CD28 Market

26.1. Eastern Europe T Cell Specific Surface Glycoprotein CD28 Market Overview

26.2. Eastern Europe T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia T Cell Specific Surface Glycoprotein CD28 Market

27.1. Russia T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America T Cell Specific Surface Glycoprotein CD28 Market

28.1. North America T Cell Specific Surface Glycoprotein CD28 Market Overview

28.2. North America T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA T Cell Specific Surface Glycoprotein CD28 Market

29.1. USA T Cell Specific Surface Glycoprotein CD28 Market Overview

29.2. USA T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada T Cell Specific Surface Glycoprotein CD28 Market

30.1. Canada T Cell Specific Surface Glycoprotein CD28 Market Overview

30.2. Canada T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America T Cell Specific Surface Glycoprotein CD28 Market

31.1. South America T Cell Specific Surface Glycoprotein CD28 Market Overview

31.2. South America T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil T Cell Specific Surface Glycoprotein CD28 Market

32.1. Brazil T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East T Cell Specific Surface Glycoprotein CD28 Market

33.1. Middle East T Cell Specific Surface Glycoprotein CD28 Market Overview

33.2. Middle East T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa T Cell Specific Surface Glycoprotein CD28 Market

34.1. Africa T Cell Specific Surface Glycoprotein CD28 Market Overview

34.2. Africa T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Segmentation By Technology, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. T Cell Specific Surface Glycoprotein CD28 Market Regulatory and Investment Landscape

36. T Cell Specific Surface Glycoprotein CD28 Market Competitive Landscape And Company Profiles

36.1. T Cell Specific Surface Glycoprotein CD28 Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. T Cell Specific Surface Glycoprotein CD28 Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. T Cell Specific Surface Glycoprotein CD28 Market Company Profiles

36.3.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

37. T Cell Specific Surface Glycoprotein CD28 Market Other Major And Innovative Companies

Becton Dickinson and Company, Regeneron Pharmaceuticals Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Sino Biological Inc., Xencor Inc., ACROBiosystems Co. Ltd., Fate Therapeutics Inc., Medigene AG, Alpine Immune Sciences Inc., Adaptimmune Therapeutics plc, OSE Immunotherapeutics SA, Creative Biolabs Inc., Rondo Therapeutics Inc.

38. Global T Cell Specific Surface Glycoprotein CD28 Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The T Cell Specific Surface Glycoprotein CD28 Market

40. T Cell Specific Surface Glycoprotein CD28 Market High Potential Countries, Segments and Strategies

40.1 T Cell Specific Surface Glycoprotein CD28 Market In 2030 - Countries Offering Most New Opportunities

40.2 T Cell Specific Surface Glycoprotein CD28 Market In 2030 - Segments Offering Most New Opportunities

40.3 T Cell Specific Surface Glycoprotein CD28 Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global T Cell Specific Surface Glycoprotein CD28 Market, Overview Of Key Products - Product Examples

Table 2: Global T Cell Specific Surface Glycoprotein CD28 Market Attractiveness, Factor-Wise Evaluation

Table 3: Global T Cell Specific Surface Glycoprotein CD28 Market, Supply Chain Analysis

Table 4: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Raw Material Providers

Table 5: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Resource Providers

Table 6: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Manufacturers (Suppliers)

Table 7: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Distributors And Channel Partners

Table 8: Global T Cell Specific Surface Glycoprotein CD28 Market, Key Technologies & Future Trends

Table 9: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Trends

Table 10: Global T Cell Specific Surface Glycoprotein CD28 Market, Major End Users

Table 11: Global T Cell Specific Surface Glycoprotein CD28 Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global T Cell Specific Surface Glycoprotein CD28 Historic Market Growth, 2020-2025, $ Billion

Table 13: Global T Cell Specific Surface Glycoprotein CD28 Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global T Cell Specific Surface Glycoprotein CD28 Market - TAM, US$ Billion, 2025

Table 15: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of FPT 155, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of FR 104, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of Lulizumab Pegol, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global T Cell Specific Surface Glycoprotein CD28 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global T Cell Specific Surface Glycoprotein CD28 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global T Cell Specific Surface Glycoprotein CD28 Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global T Cell Specific Surface Glycoprotein CD28 Market - Company Scoring Matrix

Table 100: Gilead Sciences Inc. Financial Performance

Table 101: Johnson & Johnson Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Bristol-Myers Squibb Company Financial Performance

Table 104: Takeda Pharmaceutical Company Limited Financial Performance

Table 105: Global T Cell Specific Surface Glycoprotein CD28 Market, Competitive Benchmarking (In USD Billions)

Table 106: Global T Cell Specific Surface Glycoprotein CD28 Market, Competitive Dashboard

Table 107: Global T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 109: Global, T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 110: Global, T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global T Cell Specific Surface Glycoprotein CD28 Market, Overview Of Key Products - Product Examples

Figure 2: Global T Cell Specific Surface Glycoprotein CD28 Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global T Cell Specific Surface Glycoprotein CD28 Market, Supply Chain Analysis

Figure 4: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Raw Material Providers

Figure 5: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Resource Providers

Figure 6: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Manufacturers (Suppliers)

Figure 7: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Distributors And Channel Partners

Figure 8: Global T Cell Specific Surface Glycoprotein CD28 Market, Key Technologies & Future Trends

Figure 9: Global T Cell Specific Surface Glycoprotein CD28 Market, Major Trends

Figure 10: Global T Cell Specific Surface Glycoprotein CD28 Market, Major End Users

Figure 11: Global T Cell Specific Surface Glycoprotein CD28 Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global T Cell Specific Surface Glycoprotein CD28 Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global T Cell Specific Surface Glycoprotein CD28 Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global T Cell Specific Surface Glycoprotein CD28 Market - TAM, US$ Billion, 2025

Figure 15: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of FPT 155, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of FR 104, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of Lulizumab Pegol, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global T Cell Specific Surface Glycoprotein CD28 Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global T Cell Specific Surface Glycoprotein CD28 Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global T Cell Specific Surface Glycoprotein CD28 Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, T Cell Specific Surface Glycoprotein CD28 Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global T Cell Specific Surface Glycoprotein CD28 Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global T Cell Specific Surface Glycoprotein CD28 Market - Company Scoring Matrix

Figure 100: Gilead Sciences Inc. Financial Performance

Figure 101: Johnson & Johnson Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Bristol-Myers Squibb Company Financial Performance

Figure 104: Takeda Pharmaceutical Company Limited Financial Performance

Figure 105: Global T Cell Specific Surface Glycoprotein CD28 Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global T Cell Specific Surface Glycoprotein CD28 Market, Competitive Dashboard

Figure 107: Global T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 109: Global, T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 110: Global, T Cell Specific Surface Glycoprotein CD28 Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Display Monitor Market Report 2026 - Global Outlook – By Technology ( Liquid Crystal Display (LCD), Organic Light-Emitting Diode (OLED), Micro-Light-Emitting Diode (LED), Direct-View Light-Emitting Diode (LED), Active Ma...

Holter Monitor Market Report 2026 - Global Outlook – By Product Type (Wired, Wireless), By Channel Type (3 Channel, 12 Channel, Other Channel Types), By Monitoring Capacity (Upto 7 Days, Above 7 Days), By End User (Hospi...

Steam & Air-Conditioning Supply Market Report 2026 - Global Outlook – By Type (Distribution Of Steam and Heated Air, Distribution Of Cooled Air), By Distribution Channel (Multi-Brand Stores, Exclusive Stores, Online, Oth...

Blind Spot Monitor Market Report 2026 - Global Outlook – By Product Type (Blind Spot Detection System, Blind Spot Warning Systems, Blind Spot Intervention Systems, Blind Spot Information Systems), By Component Type (Ultr...

Industrial Display Market Report 2026 - Global Outlook – By Type ( Rugged Displays, Open-Frame Monitors, Panel-Mount Monitors, Marine Displays, Video Walls), By Technology ( Liquid Crystal Display(LCD), Light-Emitting Di...

Elderly Monitors Market Report 2026 - Global Outlook – By Product (Personal Emergency Response Systems (PERS), Smart Home Systems, Medical Alert Systems, GPS Tracking Devices, Wearable Devices), By Technology (Home Tele-...

Automation Industrial Monitors Market Report 2026 - Global Outlook – By Type ( Screen Size Below 12, Screen Size Between 12-17, Screen Size Above 17), By Application ( Process Industries, Discrete Industries), By End Use...

Frequently Asked Questions

How big is the T Cell Specific Surface Glycoprotein CD28 Market?

The T Cell Specific Surface Glycoprotein CD28 market was valued at $1.62 billion in 2025, increased to $1.78 billion in 2026, and is projected to reach $2.58 billion by 2030.

What is the T Cell Specific Surface Glycoprotein CD28 market growth?

The global T Cell Specific Surface Glycoprotein CD28 market is expected to grow at a CAGR of 9.7% from 2026 to 2035 to reach $2.58 billion by 2035.

Who are the key players in T Cell Specific Surface Glycoprotein CD28 market?

Some Key Players in the T Cell Specific Surface Glycoprotein CD28 market Include, Gilead Sciences Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Becton Dickinson and Company, Regeneron Pharmaceuticals Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Sino Biological Inc., Xencor Inc., ACROBiosystems Co. Ltd., Fate Therapeutics Inc., Medigene AG, Alpine Immune Sciences Inc., Adaptimmune Therapeutics plc, OSE Immunotherapeutics SA, Creative Biolabs Inc., Rondo Therapeutics Inc. .

What is the anticipated growth trend for the T Cell Specific Surface Glycoprotein CD28 market?

Major trend in this market includes: Breakthrough CD28 Approach Aims To Minimize Off-Target Toxicity In Cancer Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the T Cell Specific Surface Glycoprotein CD28 market?

North America was the largest region in the T cell-specific surface glycoprotein CD28 market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the t cell specific surface glycoprotein cd28 market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.